H-SVYDFFVWL^-OH
Ref. 3D-PP49084
Unbestimmte Größe | Nachfragen |
Produktinformation
Peptide H-SVYDFFVWL^-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-SVYDFFVWL^-OH include the following: Trp2 Peptide-Assembled Nanoparticles with Intrinsically Self-Chelating 64Cu Properties for PET Imaging Tracking and Dendritic Cell-Based Immunotherapy against Z He, H Jia, M Zheng, H Wang, W Yang - ACS Applied Bio , 2021 - ACS Publicationshttps://pubs.acs.org/doi/abs/10.1021/acsabm.1c00480 An altered peptide ligand for naaca¯ve cytotoxic T lymphocyte epitope of TRP-2(180-188) enhanced immunogenicity Y Tang, Z Lin, B Ni, J Wei, J Han, H Wang - Cancer Immunology , 2007 - Springerhttps://link.springer.com/article/10.1007/s00262-006-0195-x Superior antitumor response induced by large stress protein chaperoned protein antigen compared with peptide antigen XY Wang , X Sun, X Chen, J Facciponte - The Journal of , 2010 - journals.aai.orghttps://journals.aai.org/jimmunol/article/184/11/6309/82273 Co-assembled and self-delivered epitope/CpG nanocomplex vaccine augments peptide immunogenicity for cancer immunotherapy X Shi, H Song, C Wang, C Zhang , P Huang - Chemical Engineering , 2020 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S1385894720319823 An In Vivo Screen to Identify Short Peptide Mimotopes with Enhanced Antitumor Immunogenicity X He , S Zhou , B Quinn, D Jahagirdar , J Ortega - Cancer immunology , 2022 - AACRhttps://aacrjournals.org/cancerimmunolres/article-abstract/10/3/314/681732 Self-assembling Bioactive Peptides for Supramolecular Cancer Immunotherapy S Li, X Yan, J van Hest - Peptide Self-Assembly and , 2024 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/9783527841264.ch22 Altered peptide ligands revisited: Vaccine design through chemically modified HLA-A2-restricted T cell epitopes R Hoppes, R Oostvogels , JJ Luimstra - The Journal of , 2014 - journals.aai.orghttps://journals.aai.org/jimmunol/article/193/10/4803/97379 Synthetic, Supramolecular, and Self-Adjuvanting CD8+ T-Cell Epitope Vaccine Increases the Therapeutic Antitumor Immunity P Yang, H Song, Z Feng , C Wang - Advanced , 2019 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/adtp.201900010 Enhancing anti-tumor immunity through local gene delivery to lymph nodes NM Dold, CM Jewell - Journal for ImmunoTherapy of Cancer, 2015 - search.proquest.comhttps://search.proquest.com/openview/c89ccc33320ef4421046e500cde24800/1?pq-origsite=gscholar&cbl=2040222 Dendritic cells break tolerance and induce protective immunity against a melanocyte differentiation antigen in an autologous melanoma model MWJ Schreurs, AAO Eggert, AJ de Boer, JLM Vissers - Cancer Research, 2000 - AACRhttps://aacrjournals.org/cancerres/article-abstract/60/24/6995/506996 In Vivo Plasmid Electroporation Induces Tumor Antigen-specific CD8+ T-Cell Responses and Delays Tumor Growth in a Syngeneic Mouse Melanoma M Kalat, Z KuÃËpcuÃË, S SchuÃËller, D Zalusky - Cancer research, 2002 - AACRhttps://aacrjournals.org/cancerres/article-abstract/62/19/5489/509241 Nanostructured SL9-CpG Lipovaccines Elicit Immune Response for the Treatment of Melanoma LM Mu, L Liu, R Liu, YF Du, Q Luo, JR Xu - International Journal of , 2019 - mdpi.comhttps://www.mdpi.com/1422-0067/20/9/2207 A modified tyrosinase-related protein 2 epitope generates high-affinity tumor-specific T cells but does not mediate therapeutic efficacy in an intradermal tumor model JA McWilliams, SM McGurran, SW Dow - The Journal of , 2006 - journals.aai.orghttps://journals.aai.org/jimmunol/article/177/1/155/37653 Comparison of recombinant adenovirus and synthetic peptide for DC-based melanoma vaccination J Steitz, D Tormo, D Schweichel, T Tuting - Cancer Gene Therapy, 2006 - nature.comhttps://www.nature.com/articles/7700894 Optimized peptide vaccines eliciting extensive CD8 T-cell responses with therapeutic antitumor effects HI Cho, E Celis - Cancer research, 2009 - AACRhttps://aacrjournals.org/cancerres/article-abstract/69/23/9012/551125 Toward personalized peptide-based cancer nanovaccines: a facile and versatile synthetic approach H Kakwere , ES Ingham, R Allen - Bioconjugate , 2017 - ACS Publicationshttps://pubs.acs.org/doi/abs/10.1021/acs.bioconjchem.7b00502 Trp2 Peptide Vaccine Adjuvanted with (R)-DOTAP Inhibits Tumor Growth in an Advanced Melanoma Model EA Vasievich, S Ramishetti, Y Zhang - Molecular , 2012 - ACS Publicationshttps://pubs.acs.org/doi/abs/10.1021/mp200350n Variation in cytotoxic T-lymphocyte responses to peptides derived from tyrosinase-related protein-2 CE Myers, SO Dionne, K Shakalya, D Mahadevan - Human immunology, 2008 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0198885907004831 A novel in silico framework to improve MHC-I epitopes and break the tolerance to melanoma C Capasso, A Magarkar , V Cervera-Carrascon - , 2017 - Taylor & Francishttps://www.tandfonline.com/doi/abs/10.1080/2162402X.2017.1319028 Novel C5a agonist-based dendritic cell vaccine in a murine model of melanoma AA Floreani, SJ Gunselman, AJ Heires, RJ Hauke - Cell cycle, 2007 - Taylor & Francishttps://www.tandfonline.com/doi/abs/10.4161/cc.6.22.4899 Hydrophobic and electrostatic interactions between cell penetrating peptides and plasmid DNA are important for stable non-covalent complexation and intracellular A Upadhya , PC Sangave - Journal of Peptide Science, 2016 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/psc.2927
Chemische Eigenschaften
Technische Anfrage zu: 3D-PP49084 H-SVYDFFVWL^-OH
Wenn Sie ein Angebot anfordern oder eine Bestellung aufgeben möchten, legen Sie stattdessen die gewünschten Produkte in Ihren Warenkorb und fordern Sie dann ein Angebot oder eine Bestellung an aus dem Warenkorb. Es ist schneller, billiger und Sie können von den verfügbaren Rabatten und anderen Vorteilen profitieren.